hVIVO (FRA:CRO) Inventories, Finished Goods : €0.00 Mil (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is hVIVO Inventories, Finished Goods?

hVIVO's quarterly finished goods increased from Jun. 2023 (€0.00 Mil) to Dec. 2023 (€0.33 Mil) but then declined from Dec. 2023 (€0.33 Mil) to Jun. 2024 (€0.00 Mil).

hVIVO's annual finished goods stayed the same from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€0.00 Mil) but then increased from Dec. 2022 (€0.00 Mil) to Dec. 2023 (€0.33 Mil).

hVIVO Inventories, Finished Goods Historical Data

The historical data trend for hVIVO's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

hVIVO Inventories, Finished Goods Chart

hVIVO Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Finished Goods

Get a 7-Day Free Trial

0.33

hVIVO Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Inventories, Finished Goods	Get a 7-Day Free Trial															-	-	-	0.33	-

hVIVO Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

hVIVO Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » hVIVO PLC (FRA:CRO) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

OPORF:USA ORPH:UK HVO:UK CRO:Germany

Address

42, New Road, Queen Mary Bioenterprises Innovation Centre, London, GBR, E1 2AX

Website

https://www.hvivo.com

hVIVO PLC is a European-focused, rare, and orphan drug consulting services platform. The principal activity of the Group is that of a rapidly growing specialist CRO pharmaceutical services company, which involves the testing of vaccines and antivirals using human-challenge clinical trials. The group is also engaged in Venn Life Sciences' Clinical Research Division, providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations.

hVIVO Headlines

No Headlines